Immunoreactivity of antimitochondrial autoantibodies in Japanese patients with primary biliary cirrhosis

James SP, Hoofnagle JH, Strober W, et al. Primary biliary cirrhosis: A model autoimmune disease. Ann Intern Med 1983; 99:500–512. Mackay IR. Autoimmune diseases of the liver: Chronic active hepatitis and primary biliary cirrhosis. In: Rose NR, Mackay IR (eds) The autoimmune diseases. Orlando: Academic, 1985;291–337. Triger DR, Berg PA, Rodes J. Epidemiology of primary biliary cirrhosis. Liver 1984;4:195–200. Hamlyn AN, Macklon AF, James O. Primary biliary cirrhosis: Geographical clustering and symptomatic onset seasonality. Gut 1983;24:940–945. Hirohara J, Inoue K. The epidemiology of primary biliary cirrhosis in Japan; comparison with that in other countries (in Japanese). Shokakibyo Seminar 1994;54:11–23. Myszor M, James OFW. The epidemiology of primary biliary cirrhosis in north-east England: An increasingly common disease? Quart J Med, New Series 1990;75:377–385. Sasaki H, Inoue K, Higuchi K, et al. Primary biliary cirrhosis in Japan: National survey by the subcommittee on autoimmune hepatitis. Gastroenterol Jpn 1985;20:476–485. Iwayama T, Leung PSC, Rowley M, et al. Comparative immunoreactive profiles of Japanese and American patients with primary biliary cirrhosis against mitochondrial autoantigens. Int Arch Allergy Immunol 1992;99:28–33. Miyachi K, Watanabe S, Yamashiki M, et al. Precipitating antimitochondrial antibodies in Japanese patients with primary biliary cirrhosis. Am J Gastroenterol 1984;79:704–709. Kaplan MM. Primary biliary cirrhosis. Adv Intern Med 1987; 32:359–378. Scheuer PJ. Primary biliary cirrhosis. In: Liver biopsy interpretation. 3rd ed. London: Bailliere Tindall, 1980;47–56. Berg PA, Klein R, Lindenborn-Fotinos J. Antimitochondrial antibodies in primary biliary cirrhosis. J Hepatol 1986;2:123–131. Stanley CJ, Perham RN. Purification of 2-oxo acid dehydrogenase multienzyme complexes from ox heart by a new method. Biochem J 1980;191:147–154. Coppel RL, McNeilage LJ, Surh CD, et al. Primary structure of the human M2 mitochondrial autoantigen in primary biliary cirrhosis: Dihydrolipoamide acetyltransferase. Proc Natl Acad Sci USA 1988;85:7317–7321. Frazer IH, Mackay IR, Jordan TW, et al. Reactivity of antimitochondrial autoantibodies in primary biliary cirrhosis: Definition of two novel mitochondrial polypeptide autoantigens. J Immunol 1985;135:1739–1745. Teoh K-L, Rowley MJ, Zafirakis H, et al. Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis: Applications of a semi-automated assay. Hepatology 1994;20:1220–1224. Van de Water J, Cooper A, Surh CD, et al. Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis. N Engl J Med 1989;320:1377–1380. Teoh K-L. Rowley MJ, Mackay IR. An automated microassay for enzyme inhibitory effects of M2 antibodies in primary biliary cirrhosis. Liver 1991;11:287–291. Rowley MJ, McNeilage LJ, Armstrong JMcD, et al. Inhibitory autoantibody to a conformational epitope of the pyruvate dehydrogenase complex, the major autoantigen in primarybiliary cirrhosis. Clin Immunol Immunopathol 1991;60:356–370. Mutimer DJ, Fussey SPM, Yeaman SJ, et al. Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis. Hepatology 1989; 10:403–407. Gershwin ME, Mackay IR, Coppel R, et al. Clinical, immunologic and molecular features of primary biliary cirrhosis. Semin Clin Immunol 1994;7:5–16. Yeaman SJ, Fussey SPM, Danner DJ, et al. Primary biliary cirrhosis: Identification of two major M2 mitochondrial autoantigens. Lancet 1988;1:1067–1070. Fussey SPM, Guest JR, James OFW, et al. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Natl Acad Sci USA 1988;85:8654–8658. Provenzano G, Diquattro O, Craxi A, et al. Immunoblotting as a confirmatory test for antimitochondrial antibodies in primary biliary cirrhosis. Gut 1993;34:544–548. Bassendine MF, Fussey SPM, Mutimer DJ, et al. Identification and characterization of four M2 mitochondrial autoantigens in primary biliary cirrhosis. Semin Liver Dis 1989:9:124–131. Tsuruya T. Detection of anti-pyruvate dehydrogenase complex antibody in primary biliary cirrhosis by an enzyme-linked immunosorbent assay. Gastroenterol Jpn 1990;25:471–477. Zurgil N, Bakimer R, Moutsopoulos HM, et al. Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases. J Clin Immunol 1992;12:201–209. Caldwell SH, Leung PSC, Spivey JR, et al. Antimitochondrial antibodies in kindreds of patients with primary biliary cirrhosis: Antimitochondrial antibodies are unique to clinical disease and are absent in asymptomatic family members. Hepatology 1992; 16:889–905. Gores GJ, Moore SB, Fisher LD, et al. Primary biliary cirrhosis; association with class II major histocompatibility complex antigens. Hepatology 1987;7:889–892. Manns MP, Bremm A, Schneider PM, et al. HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis. Gastroenterology 1991;101:1367–1373. Underhill J, Donaldson P, Bray G, et al. Susceptibility to primary biliary cirrhosis is associated with the HLA-DR8-DQB1*0402 haplotype. Hepatology 1992;16:1404–1408. Seki T, Kiyosawa K, Ota M, et al. Association of primary biliary cirrhosis with human leukocyte antigen DPB1*0501 in Japanese patients. Hepatology 1993;18:73–78. Maeda T, Onishi S, Saibara T, et al. HLA DRw8 and primary biliary cirrhosis. Gastroenterology 1992;103:1118–1119.